Chemical Price | Prices | Pricing | Monitoring | ChemAnalyst

For the Quarter Ending September 2023   North America In the third quarter of 2023, the pricing dynamics of  Clopidogrel Bisulfate API  in North America closely mirrored trends observed in the Asia-Pacific (APAC) region. Throughout Q3, prices displayed a pessimistic trend primarily attributed to a decline in demand from the downstream sector. Both local and international suppliers noted a lack of new inquiries, with Indian suppliers possessing ample capacity to meet regional and local demands. Most new orders were volume-based, and the pre-festive holiday stocking in the downstream market led to a less optimistic market outlook. Moreover, a surplus of Clopidogrel Bisulfate persisted in the local spot market, allowing merchants to fulfill incoming requirements. Weaker manufacturing activity in the pharmaceutical sectors resulted from reduced consumer demand for specific drugs or their end products, driven by unfavorable weather conditions in the middle of Q3. Addition...

For the Quarter Ending June 2023 North America The  price of clopidogrel bisulfate  in North America followed a similar declining trend as in the APAC region during the second quarter. Prices steadily decreased throughout North America compared to the first quarter, with the downward trend continuing until the last week of June. This was due to fluctuations in the downstream market for the feedstock used to make clopidogrel bisulfate, as well as a decline in local demand from the pharmaceutical sector. Market participants holding large warehouse inventories and limited consumption of existing ones also contributed to the ongoing decline in domestic demand. To reduce their inventories and protect their end products, suppliers lowered domestic prices. However, taking into account the consumer price index (CPI) for June 2023, specifically in the United States, it increased by 0.1% compared to May. Domestic suppliers of clopidogrel bisulfate had enough inventory to meet local dema...

For the Quarter Ending June 2023 North America: Clopidogrel bisulfate prices  in the North American region mirrored the declining trend seen in the APAC region. Across North America, prices for clopidogrel bisulfate steadily decreased during the second quarter, compared to the first quarter. This downward trend persisted until the final week of June. The declining prices were attributed to fluctuating downstream markets for the feedstock used in manufacturing clopidogrel bisulfate, along with a consistent decline in local demand from the pharmaceutical sector. High warehouse inventories held by market participants and limited utilization of existing stocks played a role in the ongoing decline of domestic demand. This compelled market players to reduce domestic prices in an effort to lower their inventories and safeguard their end products. Despite this, considering the consumer price index (CPI) for June 2023, specifically in the United States, it increased by 0.1% compared to May....